Athersys

Athersys Dividend Yield

Dividend Yield of Athersys (ATHXQ) as of Oct 18, 2026.

Dividend Yield

-

Last updated:

Dividend Yield of Athersys is 2026 - . Dividend Yield of Athersys was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Athersys Stock analysis

What does Athersys do? Athersys Inc, headquartered in Cleveland, Ohio, is a biotechnology company specializing in regenerative medicine. The company focuses on developing therapeutic product candidates, with its lead platform product MultiStem (invimestrocel) in late-stage clinical development. MultiStem, an allogeneic stem cell therapy derived from adult bone marrow, is being tested in Phase III trials for ischemic stroke treatment under the MASTERS-2 study. Athersys employs 24 full-time staff and went public on April 23, 2007. Athersys is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Athersys stock

On Eulerpool you can find the complete historical development of Dividend Yield Athersys since 2006 – with annual values, charts, and detailed analysis.

Dividend yield measures the annual dividend payment relative to the stock price. It shows the return an investor receives from dividends alone.

Dividend Yield's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Yield's Athersys historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Athersys

All Key Metrics — Athersys